Follow this preprint

Long-Term Persistence of IgG Antibodies in recovered COVID-19 individuals at 18 months and the impact of two-dose BNT162b2 (Pfizer-BioNTech) mRNA vaccination on the antibody response

Puya-Dehgani-Mobaraki, Chao Wang, Alessandro Floridi, Emanuela Floridi, Asiya K Zaidi
doi: https://doi.org/10.1101/2022.01.18.22269349
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2022.01.18.22269349
History 
  • January 20, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Puya-Dehgani-Mobaraki, President, MD1,
  2. Chao Wang, PhD, Senior Lecturer in Health & Social Care Statistic2,
  3. Alessandro Floridi, M.Pharm3,
  4. Emanuela Floridi, M.D3 and
  5. Asiya K Zaidi, Research Fellow, MD4,*
  1. 1Associazione Naso Sano, Umbria Regional Registry of volunteer activities, Italy Via Luca Benincasa 2, San Mariano, 06073, Perugia-Italy
  2. 2Faculty of Health, Social Care and Education, Kingston University and St George’s, University of London, London, SW17 0RE, UK
  3. 3Laboratory of Nuclear Lipid BioPathology, Centro Ricerche Analisi Biochimico Specialistiche, Perugia, Italy
  4. 4Associazione Naso Sano, Italy
  1. ↵*[Corresponding Author] Asiya Kamber Zaidi, Email: asiyazaidia{at}gmail.com
Back to top
Posted January 20, 2022.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML
Data/Code
Email
Long-Term Persistence of IgG Antibodies in recovered COVID-19 individuals at 18 months and the impact of two-dose BNT162b2 (Pfizer-BioNTech) mRNA vaccination on the antibody response
Puya-Dehgani-Mobaraki, Chao Wang, Alessandro Floridi, Emanuela Floridi, Asiya K Zaidi
medRxiv 2022.01.18.22269349; doi: https://doi.org/10.1101/2022.01.18.22269349
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

4

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.